Silent cardiac dysfunction and exercise intolerance in HIV+ men receiving combined antiretroviral therapies

AIDS

Volumn 22, Issue 18, 2008, Pages 2537-2540

  Thöni, Gilles J ^a,b,f   Schuster, Iris ^b,c   Walther, Guillaume ^a   Nottin, Stéphane ^a   Vinet, Agnès ^a   Boccara, Franck ^d   Mauboussin, Jean Marc ^e   Rouanet, Isabelle ^e   Edérhy, Stéphane ^d   Dauzat, Michel ^c   Messner Pellenc, Patick ^b,c   Obert, Philippe ^a  

^a UNIVERSITY OF AVIGNON   (France)

^b Cardiology Department   (United States)

^c University of Montpellier 1   (France)

^d Saint Antoine University   (France)

^e NÎMES UNIVERSITY HOSPITAL   (France)

^f GECEM (Groupe d'Evaluation Coeur and Muscle/Heart and Skeletal Muscle Study Group)   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOTIDE DERIVATIVE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; THYMIDINE DERIVATIVE;

ADULT; AEROBIC EXERCISE; AGE; ARTICLE; BODY SURFACE; CARDIOTOXICITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DRUG SAFETY; ECHOCARDIOGRAPHY; EXERCISE TOLERANCE; HEART DISEASE; HEART FUNCTION; HEART STROKE VOLUME; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REST; SERUM GROUP PI SYSTEM; SKELETAL MUSCLE; SMOKING; TISSUE OXYGENATION;

ADULT; ANAEROBIC THRESHOLD; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ELECTROCARDIOGRAPHY; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 57349169234     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328319806d     Document Type: Article

References (15)

1. Stringer WW. Mechanisms of exercise limitation in HIV+ individuals. Med Sci Sports Exerc 2000;32:S412-S421.
2. Cade WT, Fantry LE, Nabar SR, Shaw DK, Keyser RE. A comparison of Qt and a-vO2 in individuals with HIV taking and not taking HAART. Med Sci Sports Exerc 2003;35:1108-1117.
3. Schuster I, Thöni GJ, Edérhy S, Walther G, Nottin S, Vinet A, et al. Subclinical cardiac abnormalities in human immunodeficiency virus-infected men receiving antiretroviral therapy. Am J Cardiol 2008;101:1213-1217.
4. Hsue PY, Farah HH, Palav S, et al. Diastolic dysfunction is common in asymptomatic HIV patients. 15th Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts; 2008.
5. Karavidas A, Foukarakis M, Lazaros G, Chini M, Fotiadis I, Arapi S, et al. Assessment of cardiac function with Doppler tissue imaging in asymptomatic HIV-infected patients. Int J STD AIDS 2008;19:227-231.
6. Rowland T, Obert P. Doppler echocardiography for the estimation of cardiac output with exercise. Sports Med 2002; 32:973-986.
7. Lewis W, Grupp IL, Grupp G, Hoit B, Morris R, Samarel AM, et al. Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine. Lab Invest 2000;80:187-197.
8. Frerichs FC, Dingemans KP, Brinkman K. Cardiomyopathy with mitochondrial damage associated with nucleoside reversetranscriptase inhibitors. N Engl J Med 2002;347:1895-1896.
9. Cade T. Left ventricular dysfunction in human immunodeficiency virus infection. J Cardiometab Syndr 2008;3:83-87.
10. Aurigemma GP, Gottdiener JS, Shemanski L, Gardin J, Kitzman D. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol 2001;37:1042-1048.
11. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003;289:194-202.
12. Wei M, Kampert JB, Barlow CE, Nichaman MZ, Gibbons LW, Paffenbarger RS, Blair SN. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA 1999;282:1547- 1553.
13. Hogg K, McMurray J. The treatment of heart failure with preserved ejection fraction ('diastolic heart failure'). Heart Fail Rev 2006;11:141-146.
14. Brenner DA, Apstein CS, Saupe KW. Exercise training attenuates age-associated diastolic dysfunction in rats. Circulation 2001;104:221-226.
15. Brassard P, Legault S, Carneau C, Bogaty P, Dumesnil JG, Poirier P. Normalization of diastolic dysfunction in type 2 diabetics after exercise training. Med Sci Sports Exerc 2007;39:1896-1901.